AndroForte

AndroForte is a topical testosterone cream developed by Lawley Pharmaceuticals for the treatment of confirmed testosterone deficiency in men (male hypogonadism). It is formulated as an alcohol-free 5% w/v (50 mg/mL) cream designed for transdermal administration. As an androgen receptor agonist, it restores physiological testosterone levels in patients with clinical and biochemical evidence of androgen deficiency. The product was registered with the Australian Therapeutic Goods Administration (TGA) in November 2020 and is intended to provide a non-invasive alternative to injectable or oral testosterone replacement therapies.

Brand names

AndroForteAndroForte 5AndroForte5AndroForte-5

Other names

testosterone